Alex Biese

These are the basics of bile duct cancer, from diagnosis to treatment.

The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma.

More than a quarter of tested patients with non-small cell lung cancer responded to Amtagvi monotherapy.

The U.S. FDA has granted orphan drug designation to M2T-CD33 for the treatment of patients with acute myeloid leukemia.

Basal cell carcinoma, or BCC, is the most common form of skin cancer globally, but it is also highly curable.

CURE spoke with an areola tattoo artist and a patient who has undergone the procedure.

In honor of Pancreatic Cancer Awareness Month, we spoke with Dr. Rosario Ligresti about rising rates of the disease in younger adults and more.

The FDA granted fast track designation to JSKN003 in platinum-resistant recurrent epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer.

For Stephanie Wachtel, receiving a diagnosis of triple-positive breast cancer at the age of 23 was life-changing in a number of ways.

Exousia Pro, Inc. received orphan drug designation from the FDA for malignant glioma, also known as glioblastoma multiforme or GBM.

The FDA has approved Blenrep with BVd as a third-line treatment for relapsed or refractory multiple myeloma.

CURE spoke with experts about possible side effects faced by patients with breast cancer.

Exercise, as an expert explained to CURE, can have a significant positive impact on long-term outcomes for patients with cancer.

The FDA has approved Revuforj for relapsed or refractory acute myeloid leukemia with an NPM1 mutation.

The FDA has granted fast track designation to MT-125 for the treatment of patients with glioblastoma.

The FDA approved Blenrep with Velcade and dexamethasone for relapsed or refractory multiple myeloma.

What you need to know about stomach cancer, also known as gastric cancer.

The Food and Drug Administration granted fast track designation to HDP-101 for the treatment of multiple myeloma.

The MELODY study found music therapy to be effective at relieving the anxiety of cancer survivors.

Fran Curtis is a survivor of breast, appendix and skin cancer, but said bladder cancer was the toughest.

The FDA accepted an application for Padcev plus Keytruda for patients with muscle-invasive bladder cancer ineligible for cisplatin-containing chemotherapy.

In patients with operable, newly diagnosed brain metastases, GammaTile was associated with reduction in the risk of tumor recurrence or death.

Antibody-drug conjugate treatment rates increased 3.7-fold from 2021 to 2023 for patients with metastatic breast cancer.

The cancer vaccine IO102-IO103 plus Keytruda was associated with a clinically relevant improvement in median progression-free survival.

Lymphoma survivors with chronic fatigue participating in a multidisciplinary intervention program experienced benefits to fatigue and quality of life.

Home-based supervised physical activity has no major impact on fatigue and quality of life for patients with metastatic cancer receiving oral targeted therapy.

For patients with pancreatic cancer, this is a guide to the basics you need to know about this disease.

Addressing spirituality and religion can potentially help patients with gynecologic cancers, researchers have found.

The FDA granted fast track designation to NG-350A for the treatment of patients with mismatch repair-proficient locally advanced rectal cancer.

CURE spoke with Betsy Hamlin, who was treated with Keytruda Qlex in a clinical trial after being diagnosed with melanoma.